Laurer H, Bareyre FM, Lee V M-Y, Trojanowski JQ, L onghi L, Hoover
R, Saatman K E, Raghupathi R, Hoshino S, Grady MS, McIntosh TK
(2001) Mild head injury increases the brain's vulnerability to a second
traumatic impact. J Neurosurg 95:859 – 870.
L orenzo A, Yankner BA (1994) Beta-amyloid neurotoxicity requires
fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA
91:12243–12247.
Markesbery W R, C arney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9:133–146.
Martin JB (1999) Molecular basis of the neurodegenerative disorders.
N Engl J Med 340:1970 –1980.
McIntosh TK , Noble L, Andrews B, Faden AI (1987) Traumatic brain
injury in the rat: characterization of a midline fluid-percussion model.
C ent Nerv Syst Trauma 4:119 –134.
McIntosh TK , Vink R, Noble L, Yamakami I, Fernyak S, Soares H, Faden
AL (1989) Traumatic brain injury in the rat: characterization of a
lateral fluid-percussion model. Neuroscience 28:233–244.
Mills J, Reiner PB (1999) Regulation of amyloid precursor protein cleavage. J Neurochem 72:443– 460.
Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation
impaired in rats with hippocampal lesions. Nature 297:681– 683.
Mortimer JA, French LR, Hutton J T, Schuman L M (1985) Head injury
as a risk factor for Alzheimer's disease. Neurology 35:264 –267.
Murai H, Pierce JE, Raghupathi R, Smith DH, Saatman K E, Trojanowski
JQ, Lee V M-Y, L oring JF, Eckman C, Younkin S, McIntosh TK
(1998) T wofold overexpression of human beta-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or
neurodegenerative sequelae following experimental brain injury.
J Comp Neurol 392:428 – 438.
Nakagawa Y, Nakamura M, McIntosh TK , Rodriguez A, Berlin JA,
Smith DH, Saatman K E, Raghupathi R, C lemens J, Saido TC, Schmidt
ML, Lee V M-Y, Trojanowski JQ (1999) Traumatic brain injury in
young, amyloid-beta peptide overexpressing transgenic mice induces
marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging. J Comp Neurol 411:390 –398.
Nakagawa Y, Reed L, Nakamura M, McIntosh TK , Smith DH, Saatman
K E, Raghupathi R, C lemens J, Saido TC, Lee V M-Y, Trojanowski JQ
(2000) Brain trauma in aged transgenic mice induces regression of
established abeta deposits. E xp Neurol 163:244 –252.
Nakamura M, Saatman K E, Galvin JE, Scherbel U, Raghupathi R,
Trojanowski JQ, McIntosh TK (1999) Increased vulnerability of
N F H-LacZ transgenic mouse to traumatic brain injury-induced behavioral deficits and cortical damage. J C ereb Blood Flow Metab
19:762–770.
Nunan J, Small DH (2000) Regulation of APP cleavage by alpha-, betaand gamma-secretases. F EBS Lett 483:6 –10.
Nunomura A, Perry G, Pappolla M A, Friedland RP, Hirai K , Chiba S,
Smith M A (2000) Neuronal oxidative stress precedes amyloid-beta
deposition in Down syndrome. J Neuropathol E xp Neurol
59:1011–1017.
Pierce JE, Smith DH, Trojanowski JQ, McIntosh TK (1998) Enduring
cognitive, neurobehavioral and histopathological changes persist for up
to one year following severe experimental brain injury in rats. Neuroscience 87:359 –369.
Plassman BL, Havlik RJ, Steffens DC, Helms MJ, Newman TN, Drosdick
D, Phillips C, Gau BA, Welsh-Bohmer K A, Burke JR, Guralnik JM,
Breitner JC (2000) Documented head injury in early adulthood and
risk of Alzheimer's disease and other dementias. Neurology
55:1158 –1166.
Pratico` D (1999) F(2)-isoprostanes: sensitive and specific non-invasive
indices of lipid peroxidation in vivo. Atherosclerosis 147:1–10.
Pratico` D, Delanty N (2000) Oxidative injury in diseases of the central
nervous system: focus on Alzheimer's disease. Am J Med 109:577–585.
Pratico` D, Lee V M-Y, Trojanowski JQ, Rokach J, FitzGerald GA (1998)
Increased F2-isoprostanes in Alzheimer's disease: evidence for en- hanced lipid peroxidation in vivo. FASEB J 12:1777–1783.
Pratico` D, C lark C M, Lee V M-Y, Trojanowski JQ, Rokach J, FitzGerald
GA (2000a) Increased 8,12-iso-iPF2 -V I in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease
severity Ann Neurol 48: 809 – 812.
Pratico` D, Iuliano L, Amerio G, Tang L X, Rokach J, Sabatino G, Violi F
(2000b) Down's syndrome is associated with increased 8,12-isoiPF2 -V I levels: evidence for enhanced lipid peroxidation in vivo. Ann
Neurol 48:795–798.
Pratico` D, Uryu U, Leight S, Trojanowski JQ, Lee V M-Y (2001) In- creased lipid peroxidation precedes amyloid plaque formation in an
animal model of Alzheimer amyloidosis. J Neurosci 21:4183– 4187.
Price DL, Sisodia SS (1998) Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21:479 –505.
Qiu WQ, Walsh DM, Ye Z, Vekrellis K , Z hang J, Podlisny MB, Rosner
MR, Safavi A, Hersh L B, Selkoe DJ (1998) Insulin-degrading enzyme
regulates extracellular levels of amyloid -protein by degradation.
J Biol Chem 273:32730 –32738.
Raghupathi R, Fernandez SC, Murai H, Trusko SP, Scott RW, Nishioka
W K , McIntosh TK (1998) BCL -2 overexpression attenuates cortical
